Highly Selective Aptamer-Molecularly Imprinted Polymer Hybrids for Recognition of SARS-CoV-2 Spike Protein Variants.

SARS‐CoV‐2 aptamers molecular imprinting nanoparticles viral detection viral variants

Journal

Global challenges (Hoboken, NJ)
ISSN: 2056-6646
Titre abrégé: Glob Chall
Pays: Germany
ID NLM: 101705641

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 30 11 2022
revised: 17 01 2023
medline: 8 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: epublish

Résumé

Virus recognition has been driven to the forefront of molecular recognition research due to the COVID-19 pandemic. Development of highly sensitive recognition elements, both natural and synthetic is critical to facing such a global issue. However, as viruses mutate, it is possible for their recognition to wane through changes in the target substrate, which can lead to detection avoidance and increased false negatives. Likewise, the ability to detect specific variants is of great interest for clinical analysis of all viruses. Here, a hybrid aptamer-molecularly imprinted polymer (aptaMIP), that maintains selective recognition for the spike protein template across various mutations, while improving performance over individual aptamer or MIP components (which themselves demonstrate excellent performance). The aptaMIP exhibits an equilibrium dissociation constant of 1.61 nM toward its template which matches or exceeds published examples of imprinting of the spike protein. The work here demonstrates that "fixing" the aptamer within a polymeric scaffold increases its capability to selectivity recognize its original target and points toward a methodology that will allow variant selective molecular recognition with exceptional affinity.

Identifiants

pubmed: 37287590
doi: 10.1002/gch2.202200215
pii: GCH2202200215
pmc: PMC10242533
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2200215

Informations de copyright

© 2023 The Authors. Global Challenges published by Wiley‐VCH GmbH.

Déclaration de conflit d'intérêts

Aptamer Group has patented the aptamer sequence (Optimer) presented in this work. The academic authors have not conflicts of interest.

Références

Macromol Biosci. 2021 May;21(5):e2100002
pubmed: 33760365
Biosens Bioelectron. 2021 Apr 15;178:113029
pubmed: 33515985
Chem Mater. 2017 Jul 25;29(14):5753-5761
pubmed: 30880872
Glob Chall. 2023 Mar 20;7(6):2200215
pubmed: 37287590
Biomater Sci. 2016 Feb;4(2):281-7
pubmed: 26509192
J Mol Recognit. 2006 Mar-Apr;19(2):106-80
pubmed: 16395662
ACS Sens. 2022 Apr 22;7(4):1122-1131
pubmed: 35416035
Nanoscale Adv. 2019 Aug 21;1(9):3709-3714
pubmed: 36133545
Emerg Microbes Infect. 2020 Dec;9(1):382-385
pubmed: 32065055
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
J Med Virol. 2022 May;94(5):2019-2025
pubmed: 34997962
Adv Mater. 2015 Jan 27;27(4):750-8
pubmed: 25413444
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
J Mol Biol. 2003 Aug 29;331(5):991-1004
pubmed: 12927536
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Biosens Bioelectron. 2016 Jan 15;75:188-95
pubmed: 26318788
Nat Rev Immunol. 2021 Jun;21(6):382-393
pubmed: 33875867
Sens Actuators B Chem. 2022 Feb 15;353:131160
pubmed: 34866797
Nat Rev Microbiol. 2009 Mar;7(3):226-36
pubmed: 19198616
Anal Bioanal Chem. 2022 May;414(12):3687-3696
pubmed: 35318515
Talanta. 2022 Jan 1;236:122878
pubmed: 34635258
Methods Mol Biol. 2020;2073:183-194
pubmed: 31612443
Chem Sci. 2021 Nov 23;13(5):1263-1269
pubmed: 35222909
Mater Lett. 2022 Jan 1;306:130898
pubmed: 34566219
J Funct Biomater. 2020 Jun 17;11(2):
pubmed: 32560382
Angew Chem Int Ed Engl. 2021 Jul 26;60(31):16800-16823
pubmed: 33559947
J Mater Chem B. 2022 Sep 15;10(35):6792-6799
pubmed: 35678703
Nanoscale. 2021 Oct 21;13(40):16885-16899
pubmed: 34528987
Expert Opin Ther Targets. 2017 Feb;21(2):131-143
pubmed: 27936982
Mikrochim Acta. 2019 Jan 7;186(2):56
pubmed: 30617424
Clin Chem Lab Med. 2020 Jun 25;58(7):1144-1145
pubmed: 32386187
Public Health. 2020 Aug;185:88-90
pubmed: 32590234
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Nanomaterials (Basel). 2020 Feb 11;10(2):
pubmed: 32053989
Lancet Infect Dis. 2021 Sep;21(9):1246-1256
pubmed: 33857406
Nat Protoc. 2016 Mar;11(3):443-55
pubmed: 26866789
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Front Bioeng Biotechnol. 2019 May 24;7:115
pubmed: 31179277
Clin Microbiol Infect. 2020 Jun;26(6):729-734
pubmed: 32234451
Methods Mol Biol. 2021;2359:269-283
pubmed: 34410676

Auteurs

Mark V Sullivan (MV)

Leicester School of Pharmacy De Montfort University The Gateway Leicester LE1 9BH UK.

Francia Allabush (F)

School of Chemical Engineering University of Birmingham Edgbaston Birmingham B15 2TT UK.
School of Chemistry University of Birmingham Edgbaston Birmingham B15 2TT UK.

Harriet Flynn (H)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

Banushan Balansethupathy (B)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

Joseph A Reed (JA)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

Edward T Barnes (ET)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

Callum Robson (C)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

Phoebe O'Hara (P)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

Laura J Milburn (LJ)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

David Bunka (D)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

Arron Tolley (A)

The Aptamer Group Windmill House Innovation Way Heslington York, YO10 5BR UK.

Paula M Mendes (PM)

School of Chemical Engineering University of Birmingham Edgbaston Birmingham B15 2TT UK.

James H R Tucker (JHR)

School of Chemistry University of Birmingham Edgbaston Birmingham B15 2TT UK.

Nicholas W Turner (NW)

Leicester School of Pharmacy De Montfort University The Gateway Leicester LE1 9BH UK.

Classifications MeSH